medigraphic.com

2013, Number 2

<< Back Next >>

Revista Cubana de Angiología y Cirugía Vascular 2013; 14 (2)

Diseases and events associated to Lymphedema in El Cerro Municipality

Rodríguez VLE, Seuc JAH, García-Viniegras CRV, Pérez LD, Chirino DL, Borrás MM

Language: Spanish
References: 41
Page:
PDF size: 115.26 Kb.


ABSTRACT

Introduction: Lymphedema is a chronic disease of universal distribution, with great psychosocial impact. Its supported increase and the need of an early identification of predisposing factors have been predicted.
Objective: to identify the main diseases or events associated to Lymphedema in El Cerro Municipality.
Methods: 346 people were worked who were divided into two groups: 330 without Lymphedema and 16 with Lymphedema. A module of questions aimed at getting the necessary information was applied. Proportions were calculated and the groups were compared between them.
Results: a prevalence of inflammatory diseases was found (n= 31; 8. 95 %), followed by surgical events (n= 21; 6.06 %), cancer in any location (n= 18; 5.20 %) and congenital conditions (n=14; 4.04 %) as the most frequent events. Family antecedent of Lymphedema was confirmed only in the group of people that suffered from it. When comparing the groups between them, it was observed that recurrent lymphangitis, breast cancer, axillary surgery, axillary radiotherapy and venous thrombosis were more frequent in the group with Lymphedema and a significant association (p‹0,001) was appreciated between both groups. Neither Angiodysplasia nor Lymphatic Filariasis cases were detected.
Conclusions: in the search for ways to expect or predict the presence of Lymphedema, family antecedents of the disease, recurrent lymphangitis, breast cancer suffering, the use of radiotherapy, axillary surgery and deep venous thrombosis should be born in mind as events and associated diseases that anticipate its occurrence.


REFERENCES

  1. Segundo Consenso Latinoamericano para el Tratamiento del linfedema. Buenos Aires: Ed. Nayarit; 2005.

  2. Pereira de Godoy JM, Braile DM, de Fatima Godoy M, Longo O Jr. Quality of life and peripheral lymphedema. Lymphology. 2002 [cited 2008 Oct 5];35(2):44-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12081054

  3. Mc Waynej, Heiney SP. Psychologic and social sequelae of secondary lymphedema: a review. Cancer. 2005[cited 2008 Oct 5];104(3):457-66. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15968692

  4. Rodríguez Villalonga LE, Victoria García-Viniegra CR, Seuc Jo A, Chirino Díaz L, Leonar Pérez D, Borras Migues M. linfedema y Calidad de Vida. Rev Cubana Angiol Cir Vasc. 2012 [citado 5 Oct 2012];13(1). Disponible en:http://www.bvs.sld.cu/revistas/ang/vol13_1_12/ang07112.htm

  5. Gathin G, Byrne D, Tierney S, Strapp H, Cowman S. Prevalence of lymphoedema and quality of life among patients attending a hospital-based wound management and vascular clinic. Int Wound J. 2012;9:120-5.

  6. Campisi C, Eretta C, Pertile D, Da Rin Elisa, Campisi C, Macciò A, et al. Microsurgery for treatment of peripheral lymphedema: long-term outcome and future perspectives. Microsurgery. 2007 [cited 2009 Oct 15];27(4):333-8. Available from: http://onlinelibrary.wiley.com/doi/10.1002/micr.20346/abstract

  7. Becker C, Assouad J, Riquet M, Hidden G. Posmastectomy lymphedema: Long-term result following microsurgical node transplantation. Ann Surg. 2006 [citado 2007 Oct 1];243(3):313-5. Available from:http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1448940/

  8. Weiss JM, Spray BJ. The effect of complete decongestive therapy on the quality of life of the patients with peripheral lymphedema. Lymphology. 2002 [cited 2005 Oct 1];35(2):44-5. Available from:http://onlinelibrary.wiley.com/doi/10.1002/micr.20346/abstract

  9. Vignes S, Parcher R, Arrault M, Dupuy A. Long-term management of breast cancerrelated lymphedema after intensive descongestive physiotherapy. Breast Cancer Res Treat. 2007;101(3):285-90.

  10. Charles Edouard D. linfedema: Epidemiología en América. Linfología. 1998;4(9):37-42.

  11. Doherty D. Assessment of lymphedema of the lower limbs by the community. Br J Community Nurs. 2006;11(10):59-62.

  12. De la Osa J. Elefantiasis. Consultas Médicas. La Habana. Portal Cuba. 2012 [cited 7 Jul 2012]. Disponible en: http://consultas.cuba.cu/consultas.php?sid=0fbaa70e51d98865dba2338fb5887543 &id_cat=3&letr=e&id_cons=152

  13. García-Sancho Martín L. Diagnóstico diferencial de los edemas. En: Jiménez Cossio JA, editor. Diagnóstico y tratamiento de los linfedemas. Madrid: Uriach; 1985. p. 103- 22.

  14. Moffat CJ, Franks PJ, Doherty DC. Linfedema: An underestimated health problem. QJM. 2003 [cited 2008 Feb 26];96(10):731-8. Available from: http://www.bago.com/BagoArg/Biblio/clmedweb355.htm

  15. William AF, Frankz PJ, Moffat CJ. Lymphoedema: estimating the size of the problem. Review. Palliat Med. 2005 [cited 2008 Feb 26];19(4):300-13. Available from:http://pmj.sagepub.com/content/19/4/300.short

  16. Beaude Rochars M, Milord D, St Jean Y, Desrmaux AM, Dorvil JJ, Laffontant JG,et al. Geographic distribution of lymphatic filariasis in Haiti. Am J Trop Med Hyg. 2004;75(5):598-601.

  17. Karent T, Cuenco M, Elizabeth H, Patrick JL. Assessment of families for excess of lymphedema of the legs in a filiariasis endemic area. Am J Trop Med Hyg. 200;70(2):185-90.

  18. Rodríguez Villalonga LE, Seuc Jo A, Lauzán Díaz E, García Lazo G, Rodríguez Álvarez M, Macías Sabuqué M. linfedemas en el municipio Cerro. Rev Cubana Angiol Cir Vasc. 2012 [citado 5 Oct 2012];13(2). Disponible en:http://www.bvs.sld.cu/revistas/ang/vol13_2_12/ang03212.htm

  19. Díaz Hernández O. Análisis de los factores de riesgo en el linfedema pos mastectomía. Rev Cubana Hig Epidemiol. 2000;39(2):20-1.

  20. Ciucci JL. Retrospective study of 500 patients with Lymphedema. Excerpted from Progress in Lymphology XVI. Lymphology. 1998;31(Suppl):21-4.

  21. Deo SV, Ray S, Rath GK, Shukla NK, Kar M, Asthana S, Raina V, et al. Prevalence and risk factors for development of lymphedema following breast cancer treatment. Indian J Cancer. 2004;41(1):8-12.

  22. Arrault M, Vignes S. Risk factors for developing upper limb lymphedema after breast cancer treatment. Bull Cancer. 2006;93(10):1001-6.

  23. Degni M, Nunes P. linfedema. En: Maffei FH, editor. Doenca Vasculares Periférica. 2da ed. Rio de Janeiro (Brasil): MEDSI; 1995. p. 1083-99.

  24. Bruna J. Tipos y clasificación de linfedemas. Linfología. 1998;4(9):27-30.

  25. Hafez HM, Wolfe JHN. Lymphedema. Ann Vasc Surg. 1996;10:88-95.

  26. Ramaiah KD, Guyatt H, Ramu K, Vanamail P, Pani SP, Das PK. Treatment costs and loss of work time to individuals with chronic lymphatic filariasis in rural communities in south of India. Trop Med Int Health. 1999 [cited 2005 Mar 11];4(1):19-25. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10203169

  27. Rockley C. Impacto socioeconómico de la insuficiencia venosa crónica de los miembros inferiores. Flebology. 1995;1:1007-9.

  28. Benda K. Possible method for the prevention of primary lymphedema. Phlebolymphology. 1999;(26):19-23.

  29. Hervella M, Iglesias ME. Tumores vasculares como marcadores sindrómicos. An Sist Sanit Navar. 2004 [citado 2008 Jul 7];27(Supl.1):33-44. Disponible en: http://www.cfnavarra.es/salud/anales/textos/vol27/sup1/pdf/04- Tumores%20vasculares.pdf

  30. Beesley V, Janda M, Eakin E, Obermair A, Battistutta D. Lymphedema after gynecological cancer treatment: prevalence, correlates, and supportive care needs. Cancer. 2007;15;109(12):2607-14.

  31. Lozano González Y. linfedema. Rev Médica Electrónica. 2007 [citado 12 Oct 2012];29(1). Disponible en: http://www.revmatanzas.sld.cu/revistamedica/ano2007/vol12007/tema08.htm

  32. Coutin Marie G, Borges Soria j, Batista Moliner R, Herrera León L. Incrementar la esperanza de vida: Una posibilidad real. Rev Cubana Hig Epidemiol. 2000 [citado 7 Jul 2008];38(2):102-11. Disponible en:http://www.scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561 - 30032000000200003

  33. Nardone L, Palazzoni G, D'Angelo E, Deodato F, Gambacorta MA, Miccichè F, et al. Impact of dose and volume on of the lymphedema. Rays.2005 Apr-Jun;30(2):149-55. [cited 2006 Nov 7]. Available from:http://www.ncbi.nlm.nih.gov/pubmed/16294908

  34. Fernández de la Vara L. Linfangitis. Frecuencia en un sector de salud. Rev Cubana Med 1986;25(11):1084-7.

  35. Fernández de la Vara L. Frecuencia de la linfangitis en el cuerpo de guardia. Estudio epidemiológico. Rev Cubana Hig Epidemiol. 1983;2(2):114-22.

  36. Priullet P, Pussiant A. Linfangitis aguda de los miembros inferiores. Circulation. 1984:80-6.

  37. Rodríguez Villalonga LE, Reynaldo Concepción D, Quiñones Castro M, Rodríguez Lacaba B. Linfangitis necrotizante ¿Un nuevo comportamiento? Rev Cubana Angiol Cir Vasc. 2000 [citado 7 Nov 2007];1(1):16-21. Disponible en:http://www.bvs.sld.cu/revistas/ang/vol1_1_00 /ang04100.htm

  38. la Torre A. Linfangitis erisipeloide. Un nuevo concepto. Linfología. 2002;8(21):39- 46.

  39. Mc Pherson T, Persaud S, Singh S, Fay MP, Addis D, Nutman TB, et al. Interdigital lesions and frequency of acute dermatolymphangioadenitis in lymphoedema in a filariasis-endemic area. Br J Dermatol. 2006;154(5):933.

  40. Caetano M, Amorín J. Erysipelas.Acta Med Port. 2005;18(5):385-93.

  41. Pavlotsky F. Amrani S, Trau H.Recurrent erysipelas: risk factors. J Dtsch Dermatol Ges. 2004;2(2):89-95.




2020     |     www.medigraphic.com